Portugal’s president tests positive; Lebanon tightens restrictions as infections skyrocket; ‘Reckless’ Christmas rule relaxation blamed for Ireland surge
- England told to prepare for worst weeks of Covid pandemic
- China agrees to let in WHO team investigating Covid origins
- French vaccine scepticism reflects ‘dissatisfaction with politicians’
- See all our coronavirus coverage
Immunity from Moderna Inc’s Covid-19 vaccine should last at least a year, the company said on Monday at the JP Morgan Healthcare conference.
The drugmaker said it was confident that the messenger RNA (mRNA) technology it used was well suited to deploy a vaccine based on the new variant of the coronavirus which has emerged in a handful of countries.
The company’s vaccine, mRNA-1273, uses synthetic mRNA to mimic the surface of the coronavirus and teach the immune system to recognize and neutralize it.
Moderna said in December it would run tests to confirm the vaccine’s activity against any strain.
The company said on Monday it expects to deliver between 600 million doses and 1 billion does of its vaccine in 2021 and forecast vaccine-related sales of $11.7 billion for the year, based on advance purchase agreements signed with governments.
“The team feels very comfortable with the track record we have now ... that we are on track to deliver at least 600 million doses,” Chief Executive Officer Stéphane Bancel said.
Despite vaccines against Covid-19 being rolled out in a number of countries, the World Health Organization warned Monday that herd immunity would not be achieved this year.
AFP: Countries across the globe are looking forward to vaccines finally allowing a return to normality in the months ahead.
Continue reading...from The Guardian https://ift.tt/2Ka4pSe